基于全球视角下的中国结核病负担现状与趋势分析

崔怡然; 宇传华

doi:10.16462/j.cnki.zhjbkz.2020.03.003

基于全球视角下的中国结核病负担现状与趋势分析

doi: 10.16462/j.cnki.zhjbkz.2020.03.003

崔怡然,
宇传华^,

430071 武汉, 武汉大学健康学院

基金项目: 国家重点研发计划课题(2018YFC1315302, 2017YFC1200502);国家自然科学基金(81773552)

详细信息

通讯作者:
宇传华, E-mail:yuchua@whu.edu.cn

中图分类号: R52;R181
计量
- 文章访问数: 689
- HTML全文浏览量: 286
- PDF下载量: 98
- 被引次数: 0
出版历程
- 收稿日期: 2019-09-26
- 修回日期: 2019-11-28
- 刊出日期: 2020-03-10

Analysis on the status and trend of TB burden in China from the global views

CUI Yi-ran,
YU Chuan-hua^,

School of Health Sciences, Wuhan University, Wuhan 430071, China

Funds: National Key Research and Development Program of China(2018YFC1315302, 2017YFC1200502); National Natural Science Foundation of China(81773552)

More Information

Corresponding author: YU Chuan-hua, E-mail:yuchua@whu.edu.cn

摘要

摘要: 目的分析中国1990-2017年结核病的患病、发病、死亡、伤残调整寿命年(disability adjusted life year, DALY)的现状及趋势, 为结核病的防控提供参考依据。方法从健康指标和评估研究所(institute for health metrics and evaluation, IHME)网站获取1990-2017年中国、美国、印度、日本和全球的结核病(标化)患病率、(标化)发病率、(标化)死亡率、(标化)DALY率等指标, 对比分析这些指标随年份变化情况。结果 2017年中国结核病的患病率、发病率、死亡率、DALY率的高年龄组高于低年龄组。结核病患病率、发病率、死亡率、DALY率均是男性大于女性, 患病率男性、女性分别为29 641.59/10万、28 803.26/10万, 发病率男性、女性分别为72.23/10万、44.85/10万, 死亡率男、女分别为3.85/10万、1.67/10万, DALY率男性、女性分别为156.95/10万、84.73/10万。在1990-2017年间, 结核病的患病率从1990年的32 178.39/10万下降至2017年的29 231.30/10万, 结核病的发病率从1990年的141.83/10万下降到2017年的58.83/10万, 结核病的死亡率从1990年的13.82/10万下降到2017年的2.78/10万, 结核病的DALY率从1990年的582.87/10万下降到2017年的121.60/10万。结论 1990-2017年间中国结核病的疾病负担下降明显, 但与发达国家比较仍有一定差距, 仍需做出进一步努力, 降低结核病的发病率与死亡率。
- 结核病 /
- 患病率 /
- 发病率 /
- 死亡率 /
- 伤残调整寿命年
Abstract: Objective To analyze the status and trends for the prevalence, morbidity, mortality, and DALY of tuberculosis(TB) in China from 1990 to 2017, so as to provide scientific basis for TB prevention and control. Methods From 1990 to 2017 in China, the United States, India, Japan, and the global, the TB(standardized) prevalence, (standardized) morbidity, (standardized) mortality, and(standardized) DALY rates were obtained from Institute for Health Metrics and Evaluation(IHME) website, and comparative analysis of changes in these indicators with years were carried out. Results In 2017, the prevalence, morbidity, mortality, and DALY rate of TB in China were higher in the high-age group than in the low-age group. The prevalence, morbidity, mortality, and DALY rates were all higher for males than females. The prevalence was 29 641.59/100 000 and 28 803.26/100 000 for male and female, respectively. The male and female mortality rates were 72.23/100 000 and 44.85/100 000. The male and female mortality rates were 3.85/100 000 and 1.67/100 000, and the DALY rate of male and female were 156.95/100 000 and 84.73/100 000. From 1990 to 2017, the prevalence of TB decreased from 32 178.39/100 000 in 1990 to 29 231.80/100 000 in 2017, the morbidity rate of TB decreased from 141.83/100 000 in 1990 to 58.83/100 000 in 2017, the mortality rate of TB decreased from 13.82/100 000 in1990 to 2.78/100 000 in 2017, and the DALY rate of TB decreased from 582.87/100 000 in 1990 to 121.60/100 000 in 2017. Conclusions The burden of TB in China declined markedly from 1990 to 2017. Although some progress has been made in the prevention and treatment of TB in China, but there is still a certain gap compared with developed countries. It is still necessary to further reduce the morbidity rate and mortality rate of TB.
- Tuberculosis /
- Prevalence /
- Morbidity /
- Mortality /
- DALY

HTML全文

图 1 2017年中国结核病不同年龄组的死亡率、发病率和DALY

Figure 1. Chinese TB mortality, morbidity, DALY in different age, 2017

下载: 全尺寸图片幻灯片

2A 1990-2017年中国、美国、印度、日本及全球结核病患病率

2A. Prevalence of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

2B 1990-2017年中国、美国、印度、日本及全球结核病标化患病率

2B. Standardized prevalence of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

图 3 1990-2017年中国、美国、印度、日本及全球结核病标化发病率

Figure 3. Standardized morbidity of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

图 4 1990-2017年中国、美国、印度、日本及全球结核病标化死亡率

Figure 4. Standardized mortality of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

5A 1990-2017年中国、美国、印度、日本及全球结核病DALY率

5A. DALY of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

5B 1990-2017年中国、美国、印度、日本及全球结核病标化DALY率

5B. Standardized DALY of TB in China, USA, India, Japan and global from 1990 to 2017

下载: 全尺寸图片幻灯片

表 1 中国不同性别结核病的DALY率和标化DALY率

Table 1. DALY and standardized DALY of TB by sex, China

年份	DALY率(1/10万)			标化DALY率(1/10万)
年份	男性	女性	合计	男性	女性	合计
1990	679.60	479.80	582.87	778.13	516.73	645.80
1991	663.44	464.84	567.36	758.41	503.79	629.73
1992	643.33	444.47	547.17	729.20	482.79	604.93
1993	612.30	418.92	518.84	687.52	454.25	570.01
1994	575.15	389.66	485.53	640.02	421.79	530.10
1995	547.07	365.13	459.17	603.10	394.72	498.12
1996	514.35	337.35	428.83	564.22	366.05	464.47
1997	482.12	306.57	397.27	526.64	334.12	429.85
1998	457.07	279.46	371.17	497.00	305.75	400.86
1999	437.06	257.39	350.09	472.21	281.96	376.54
2000	417.59	235.46	329.36	447.48	257.92	352.18
2001	379.13	215.14	299.60	406.11	234.66	319.70
2002	344.05	193.94	271.18	367.15	210.75	288.16
2003	312.95	172.67	244.79	330.75	185.41	257.12
2004	291.71	159.75	227.54	302.28	167.93	234.16
2005	268.90	145.53	208.86	273.62	150.50	211.23
2006	245.60	131.52	190.05	245.27	133.99	188.86
2007	229.42	120.13	176.17	224.54	120.31	171.72
2008	220.20	111.97	167.44	211.83	110.87	160.70
2009	212.27	106.08	160.48	200.99	103.73	151.73
2010	204.86	101.14	154.24	190.97	97.74	143.73
2011	197.46	96.46	148.14	180.99	92.09	135.95
2012	190.74	92.82	142.90	171.38	87.05	128.68
2013	182.94	90.41	137.72	161.01	83.13	121.60
2014	177.74	89.22	134.47	153.30	80.42	116.42
2015	173.17	88.26	131.65	147.19	78.50	112.42
2016	166.50	86.65	127.44	138.61	75.15	106.43
2017	156.95	84.73	121.60	129.06	72.17	100.14

下载: 导出CSV

参考文献(14)

[1]	Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014, 384(9947): 1005–1070. DOI: 10.1016/S0140-6736(14)60844-8.
[2]	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
[3]	World Health Organization. Global tuberculosis report 2017[R]. Geneva, 2017: 1-262.
[4]	Institute for Health Metrics and Evaluation. Global Health Data Ex-change[EB/OL]. (2018-11-10)[2019-09-26]. http://ghdx.healthdata.org/geography/china.
[5]	GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788. DOI: 10.1016/S0140-6736(18)32203-7.
[6]	宇传华, 崔芳芳.全球疾病负担研究及其对我国的启示[J].公共卫生与预防医学, 2014, 25(2): 1-5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ggwsyyfyx201402001 Yu CH, Cui FF. Global disease burden research and its enlightenment to China[J]. J Pub Health and Prev Med, 2014, 25(2): 1-5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ggwsyyfyx201402001
[7]	秦国双, 温昊于, 宇传华.中国COPD的患病发病及YLD现状及趋势[J].公共卫生与预防医学, 2019, 30(2): 4-8. DOI: 10.3969/j.issn.1006-2483.2019.02.002. Qin GS, Wen HY, Yu CH. The prevalence incidence and YLD status and trend of COPD in China[J]. J Pub Health and Prev Med, 2019, 30(2): 4-8. DOI: 10.3969/j.issn.1006-2483.2019.02.002.
[8]	Zhang H, Xin H, Li X, et al. A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China[J]. PLoS One, 2017, 12(4): e0175183. DOI: 10.1371/journal.pone.0175183.
[9]	GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015[J]. Lancet Infect Dis, 2018, 18(3): 261–284. DOI: 10.1016/S1473-3099(17)30703-X.
[10]	毛宁, 梁爽, 何琳, 等. 2009-2014年辽宁省结核病流行特征分析[J].中华疾病控制杂志, 2017, 21(3): 287-290. DOI: 10.16462/j.cnki.zhjbkz.2017.03.017. Mao N, Liang S, He L, et al. Analysis on the epidemiological characteristics of tuberculosis in Liaoning Province, 2009-2014[J]. Chin J Dis Control Prev, 2017, 21(3): 287-290. DOI: 10.16462/j.cnki.zhjbkz.2017.03.017.
[11]	王黎霞, 成诗明, 陈明亭, 等. 2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志, 2012, 34(8): 485-508. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgflzz201208001 Wang LX, Cheng SM, Chen MT, et al. The fifth national tuberculosis epidemiological sample survey report in 2010[J]. Chin J Antituberc, 2012, 34(8): 485-508. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgflzz201208001
[12]	Kamineni VV, Wilson N, Das A, et al. Addressing poverty through disease control programmes: examples from Tuberculosis control in India[J]. Int J Equity Health, 2012, 11: 17. DOI: 10.1186/1475-9276-11-17.
[13]	刘婧楠, 李政, 王燕玲, 等.运用健康信念模式分析中学生结核病就诊意向的影响因素[J].中华疾病控制杂志, 2019, 23(1): 60-64. DOI: 10.16462/j.cnki.zhjbkz.2019.01.013. Liu JN, Li Z, Wang YL, et al. Analysis of factors influencing the intention of tuberculosis in middle school students by using health belief model[J]. Chin J Dis Control Prev, 2019, 23(1): 60-64. DOI: 10.16462/j.cnki.zhjbkz.2019.01.013.
[14]	马永成, 王兆芬, 李斌, 等.基于GIS的青海省结核病时空分布特征研究[J].中华疾病控制杂志, 2018, 22(4): 340-344. DOI: 10.16462/j.cnki.zhjbkz.2018.04.005. Ma YC, Wang ZF, Li B, et al. Temporal and spatial distribution of tuberculosis in Qinghai Province based on GIS[J]. Chin J Dis Control Prev, 2018, 22(4): 340-344. DOI: 10.16462/j.cnki.zhjbkz.2018.04.005.